中国结合医学杂志（英文版）Chinese Journal of Integrative Medicine

Author Name	Affiliation	E-mail
Xue-mei Gu	Beijing Military General Hospital, Beijing, 100700, China	guxuemei_58@yahoo.com.cn
Zhao-feng Jiang	Beijing Key Laboratory of Bioactive Substances and Functional Foods, Beijing Union University, Beijing, 100191, China College of Arts and Science, Beijing Union University, Beijing, 100191, China
Han-chang Huang	Beijing Key Laboratory of Bioactive Substances and Functional Foods, Beijing Union University, Beijing, 100191, China College of Arts and Science, Beijing Union University, Beijing, 100191, China

Hits: 948

Download times: 439

Abstract:

Alzheimer’s disease (AD) is a devastating late-life dementia that produces progressive loss of memory and mental faculties in elderly people. It is important to identify the earliest evidence of AD and to monitor the development of this disease for us to make positive response to its management. Magnetic resonance imaging (MRI) is powerful to image the tissue or organ without damnification. MRI can be employed to diagnose the early AD development and monitor the key biomarker development in AD. MRI may be helpful not only in diagnosing early AD, but also in evaluating its development. This article reviews the progress of MRI on the diagnosis and detection of AD, and makes comments on its therapeutic application.